NCT06138613View on ClinicalTrials.gov

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

PHASE3RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Motion Sickness
Interventions
DRUG

Tradipitant

Oral Capsule

Trial Locations (1)

90404

RECRUITING

Santa Monica Clinical Trials, Santa Monica

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY